SARC018: A Study of Mocetinostat and Gemcitabine in Patients With Metastatic Leiomyosarcoma

NCT02303262 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Leiomyosarcoma

Interventions

DRUG: Mocetinostat
DRUG: Gemcitabine

Sponsor

Sarcoma Alliance for Research through Collaboration